chr19-11378051-T-C

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_000121.4(EPOR):​c.1460A>G​(p.Asn487Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00665 in 1,614,018 control chromosomes in the GnomAD database, including 53 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0061 ( 8 hom., cov: 32)
Exomes 𝑓: 0.0067 ( 45 hom. )

Consequence

EPOR
NM_000121.4 missense

Scores

5
12

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5O:2

Conservation

PhyloP100: 3.54

Publications

27 publications found
Variant links:
Genes affected
EPOR (HGNC:3416): (erythropoietin receptor) This gene encodes the erythropoietin receptor which is a member of the cytokine receptor family. Upon erythropoietin binding, this receptor activates Jak2 tyrosine kinase which activates different intracellular pathways including: Ras/MAP kinase, phosphatidylinositol 3-kinase and STAT transcription factors. The stimulated erythropoietin receptor appears to have a role in erythroid cell survival. Defects in the erythropoietin receptor may produce erythroleukemia and familial erythrocytosis. Dysregulation of this gene may affect the growth of certain tumors. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2010]
EPOR Gene-Disease associations (from GenCC):
  • primary familial polycythemia due to EPO receptor mutation
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0038110912).
BP6
Variant 19-11378051-T-C is Benign according to our data. Variant chr19-11378051-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 16598.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 931 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EPORNM_000121.4 linkc.1460A>G p.Asn487Ser missense_variant Exon 8 of 8 ENST00000222139.11 NP_000112.1
EPORNR_033663.2 linkn.1817A>G non_coding_transcript_exon_variant Exon 8 of 8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EPORENST00000222139.11 linkc.1460A>G p.Asn487Ser missense_variant Exon 8 of 8 1 NM_000121.4 ENSP00000222139.5

Frequencies

GnomAD3 genomes
AF:
0.00611
AC:
929
AN:
152020
Hom.:
8
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00174
Gnomad AMI
AF:
0.00440
Gnomad AMR
AF:
0.00799
Gnomad ASJ
AF:
0.00317
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00270
Gnomad FIN
AF:
0.0211
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00700
Gnomad OTH
AF:
0.00335
GnomAD2 exomes
AF:
0.00626
AC:
1572
AN:
251316
AF XY:
0.00602
show subpopulations
Gnomad AFR exome
AF:
0.00117
Gnomad AMR exome
AF:
0.00792
Gnomad ASJ exome
AF:
0.00169
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0186
Gnomad NFE exome
AF:
0.00674
Gnomad OTH exome
AF:
0.00603
GnomAD4 exome
AF:
0.00670
AC:
9798
AN:
1461880
Hom.:
45
Cov.:
32
AF XY:
0.00654
AC XY:
4755
AN XY:
727236
show subpopulations
African (AFR)
AF:
0.000717
AC:
24
AN:
33480
American (AMR)
AF:
0.00751
AC:
336
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00168
AC:
44
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.00249
AC:
215
AN:
86258
European-Finnish (FIN)
AF:
0.0187
AC:
1000
AN:
53410
Middle Eastern (MID)
AF:
0.00381
AC:
22
AN:
5768
European-Non Finnish (NFE)
AF:
0.00703
AC:
7820
AN:
1112008
Other (OTH)
AF:
0.00556
AC:
336
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
613
1226
1839
2452
3065
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
302
604
906
1208
1510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00612
AC:
931
AN:
152138
Hom.:
8
Cov.:
32
AF XY:
0.00663
AC XY:
493
AN XY:
74388
show subpopulations
African (AFR)
AF:
0.00174
AC:
72
AN:
41488
American (AMR)
AF:
0.00811
AC:
124
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.00317
AC:
11
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00291
AC:
14
AN:
4816
European-Finnish (FIN)
AF:
0.0211
AC:
224
AN:
10610
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00699
AC:
475
AN:
67980
Other (OTH)
AF:
0.00331
AC:
7
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
48
96
143
191
239
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00512
Hom.:
2
Bravo
AF:
0.00469
TwinsUK
AF:
0.00458
AC:
17
ALSPAC
AF:
0.00752
AC:
29
ESP6500AA
AF:
0.00227
AC:
10
ESP6500EA
AF:
0.00767
AC:
66
ExAC
AF:
0.00571
AC:
693
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.00632
EpiControl
AF:
0.00575

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5Other:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Jan 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jun 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

EPOR: BP4, BS2

Primary familial polycythemia due to EPO receptor mutation Benign:1Other:2
Feb 15, 1996
OMIM
Significance:Affects
Review Status:no assertion criteria provided
Collection Method:literature only

GeneReviews
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

not specified Benign:1
Mar 04, 2025
Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.087
BayesDel_addAF
Benign
-0.56
T
BayesDel_noAF
Benign
-0.58
CADD
Benign
19
DANN
Uncertain
1.0
DEOGEN2
Benign
0.34
T
Eigen
Benign
-0.30
Eigen_PC
Benign
-0.17
FATHMM_MKL
Uncertain
0.86
D
LIST_S2
Benign
0.80
T
MetaRNN
Benign
0.0038
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.4
M
PhyloP100
3.5
PrimateAI
Benign
0.34
T
PROVEAN
Benign
-1.4
N
REVEL
Benign
0.036
Sift
Uncertain
0.019
D
Sift4G
Uncertain
0.033
D
Vest4
0.23
ClinPred
0.026
T
GERP RS
4.5
Varity_R
0.095
gMVP
0.68
Mutation Taster
=87/13
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs62638745; hg19: chr19-11488727; COSMIC: COSV55801754; COSMIC: COSV55801754; API